Our mission is to discover new ways to improve people's quality of life and extend people's lives. Our broad global portfolio comprises about 1,500 quality biosimilar and generic medicines. We provide more than 800 million patient treatments per year. The main strength of the large portfolio is our position as a global leader in the segment of biosimilar medicines, advanced innovative medicines whose patent has expired and antibiotics, which are also the foundation of the world's health systems.